For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
In the latest session, Immunovant Inc (NASDAQ: IMVT) closed at $15.31 down -1.16% from its previous closing price of $15.49. In other words, the price has decreased by -$1.16 from its previous closing price. On the day, 0.97 million shares were traded.
Ratios:
For a deeper understanding of Immunovant Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 11.16 and its Current Ratio is at 11.16. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Jefferies on March 03, 2025, initiated with a Hold rating and assigned the stock a target price of $20.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jun 13 ’25 when WILLIAM MACIAS bought 50,000 shares for $15.57 per share.
WILLIAM MACIAS bought 80,000 shares of IMVT for $1,248,616 on Jun 03 ’25. On May 21 ’25, another insider, GEORGE V MIGAUSKY, who serves as the Former Director of the company, bought 21,812 shares for $14.58 each.
Stock Price History:
Over the past 52 weeks, IMVT has reached a high of $34.47, while it has fallen to a 52-week low of $12.72. The 50-Day Moving Average of the stock is 2.31%, while the 200-Day Moving Average is calculated to be -32.51%.
Shares Statistics:
A total of 170.11M shares are outstanding, with a floating share count of 68.57M. Insiders hold about 59.89% of the company’s shares, while institutions hold 55.66% stake in the company.
